Assembly of Immunoglobulin Light Chains as a Prerequisite for Secretion
A MODEL FOR OLIGOMERIZATION-DEPENDENT SUBUNIT FOLDING*

(Received for publication, September 5, 1996, and in revised form, November 7, 1996)

Klaus Leitzgen , Michael R. Knittler Dagger and Ingrid G. Haas §

From the Institut für Biochemie I der Universität Heidelberg, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Oligomeric proteins usually have to assemble into their final quartenary structure to be secreted. However, most immunoglobulin (Ig) light (L) chains can be exported as free chains, whereas only a few Ig L chains, here referred to as export-incompetent, have to assemble with Ig heavy (H) chains into antibody molecules to be secreted. In the absence of Ig H chain expression, these export-incompetent Ig L chains remain bound to BiP as partially folded monomers with only one of the two internal disulfide bonds being formed. To understand the apparent discrepancy in Ig L chain export, we performed assembly studies with chimeric Ig chains and found that the variable (V) domain of the export-incompetent NS1 kappa  chain cannot mediate homodimer formation. Conversely, the V domain of the export-competent J558L lambda 1 chain supports homodimer formation and, concordantly, these Ig L chains are secreted as noncovalently or covalently linked homodimers. We show that the export-incompetent mutant lambda 1 FS62 chain forms disulfide bonds in both domains only upon pairing with Ig H chain and is secreted as part of an antibody. Therefore, Ig L chain assembly seems to be a prerequisite for complete folding, indicating that Ig L chain secretion generally depends on either homo- or heterodimer formation. We discuss a mechanism that controls oligomerization by monitoring the conformation of individual subunits that cannot proceed in folding prior to successful assembly.


INTRODUCTION

In eukaryotic cells, various soluble and membrane-bound proteins travel along the secretory pathway to reach their final destination. These molecules first enter the endoplasmic reticulum (ER)1 as unfolded polypeptides, which are modified there to reach their final three-dimensional structure. Attributes such as conformation, structure of attached carbohydrates, and oligomeric state not only control the functional properties of a protein but are also critical for intracellular transport. Newly synthesized polypeptides are hampered in exiting the ER as long as they have not acquired a so-called export-competent conformation (for reviews, see Refs. 1-3). Oligomeric proteins such as influenza hemagglutinin or vesicular stomatitis virus glycoprotein are homo-oligomers that must be trimerized prior to exit from the ER (4-6). In other cases, export is not dependent on complete assembly. While the heptameric T-cell receptor complex only reaches the cell surface when completely assembled, in the absence of zeta  chain homodimer association, pentamers leave the ER and are subsequently transported to lysosomes instead. Other assembly intermediates or isolated subunits are retained in the ER (7). The export of major histocompatibility complex class I antigens usually depends on the noncovalent assembly of a transmembrane heavy chain, the soluble beta 2-microglobulin, and peptide (8), but soluble beta 2-microglobulin can be secreted as free chains (9). Similarly, free immunoglobulin (Ig) heavy (H) chains are not exported (10, 11) unless assembled with Ig light (L) chains into antibody molecules (12), while most Ig L chains can also be secreted as free molecules (13, 14). Astonishingly, some Ig L chains (here referred to as export-incompetent) do not follow this rule but depend on Ig H chain association to be secreted (14-16). To date, there is no valid model to explain this apparent discrepancy.

Using immunoglobulins as a model to study the requirements of ER export, Sitia and colleagues have uncovered a quality control mechanism that acts on polypeptides to expose unpaired cysteine residues (17-20). Immunoglobulin L chains possess five cysteine residues, four of which are involved in two disulfide bonds that stabilize the variable (V) and constant (C) domain, respectively, and a carboxyl-terminal cysteine that is responsible for the intermolecular disulfide bond to Ig H chain. The thiol group of the carboxyl-terminal cysteine of unassembled Ig L chains causes a delay in secretion because it forms reversible disulfide bonds with the protein matrix of the ER (21). However, secreted Ig L chains no longer possess unpaired cysteines since the two internal disulfide bonds have already formed (22) and the carboxyl-terminal cysteine is either covalently linked to a second Ig L chain (or to Ig H chain) or paired with a free cysteine (21, 23).

Export-incompetent Ig L chains, which are not secreted in the absence of Ig H chains may also covalently interact with ER matrix proteins. However, the major cause of retention is probably the noncovalent binding to BiP, an ER-resident molecular chaperone (24, 25). It seems that only one of the domains can fold in vivo because such Ig L chains occur as partially oxidized BiP-bound monomers until they are degraded (22, 26). Complete oxidation of the Ig L chain reflecting disulfide bond formation in the second domain is only observed upon in vitro dissociation from BiP (22). As protein export is thought to be restricted to completely folded molecules, we reasoned that oligomerization might be a prerequisite for Ig L chain folding because Ig H chain association is sufficient to restore export competence to otherwise partially folded molecules.

The experiments reported here were designed to better understand the molecular mechanism underlying Ig L chain maturation and export. We have established an experimental system that allows us to investigate the capacity of particular V domains to pair with each other and found that not all support Ig chain assembly. Furthermore, we analyzed the in vivo folding state of unassembled and assembled Ig L chains. We will discuss our results with respect to the possible folding pathway of Ig L chains as well as to the general mechanism of quality control in the ER.


EXPERIMENTAL PROCEDURES

Expression Vectors

Expression vector pgamma 3 (named B1-8.VHCgamma 3 in Ref. 27) is derived from pECgamma 3 (28) and contains the gene segments encoding the mouse gamma 3 Ig H chain constant (C) region and the rearranged Ig H chain B1.8 variable (V) region. pSVE2neolambda 1 (22) encodes wild type Balb/c lambda 1 Ig L chain. pEVHCkappa neo carries the rearranged Ig H chain B1.8 V region gene segment (27) together with the mouse kappa  chain C region gene segment. To construct pEVkappa Cgamma 3, the rearranged V region gene segment of the kappa  chain-expressing myeloma MOPC21 was isolated from the plasmid pB1-14 (29) as a 2.3-kilobase SacI fragment, inserted into the SacI site of pBluescript KS+ (Stratagene, La Jolla, CA), re-excised as EcoRI/SalI fragment, and recloned into the expression vector pECgamma 3, which had been digested similarly. To construct pEVlambda Cgamma 3, the rearranged V region gene segment of the lambda 1 chain-expressing myeloma A8-6 (identical to myeloma A8-8; Ref. 30) was taken as a 2.6-kilobase EcoRI/BamHI fragment from pSVE2neolambda 1 (22), subcloned into pBluescript KS+, re-excised as an EcoRI/SalI fragment, and ligated into pECgamma 3, which had been similarly digested.

Cell Lines and Transfections

Mouse myeloma X63Ag8.653 and hybridoma H62 express no Ig chains (31, 32). J558L is a Ig H chain loss variant of the mouse plasmacytoma J558 (alpha , lambda 1; Ref. 16). NS1 is a mouse plasmacytoma synthesizing but not secreting kappa  chains (15). NSFS62 is a stable transfectant of NS1 that lost endogenous kappa  chain and expresses the export-incompetent Ig L chain lambda 1 FS62 (22). Cell line E7.lambda 1 was obtained by transfecting E7 (a stable transfectant of H62 that expresses gamma 3 Ig H chains (33) bearing the B1.8 VH domain (34)) with pSVE2neolambda 1. J558L.gamma 3 co-expresses endogenous lambda 1 chain and the same gamma 3 chain as E7 (a generous gift of T. Simon). Transfection of NSFS62 with pgamma 3 gave rise to NSFS62.gamma 3 (lambda 1 FS62 Ig L and gamma 3 Ig H chains). NS1.gamma 3 is a stable transfectant of NS1 and expresses endogenous kappa  Ig L and the pgamma 3-encoded Ig H chain. The transfectant NS1.Vkappa Cgamma 3 co-expresses the endogenous kappa  Ig L chain and the vector-encoded chimeric Vkappa Cgamma 3 Ig H chain. J558L.Vlambda Cgamma 3 derives from J558L and co-expresses endogenous lambda 1 Ig L chain and the chimeric Vlambda Cgamma 3 Ig H chain. II4c.MEV (co-expressing chimeric VHCkappa Ig L and Vkappa Cgamma 3 Ig H chains) was made by co-transfection of H62 with pEVHCkappa .neo and pEVkappa Cgamma 3. All cells were maintained as described (24). Transfection of cells by electroporation and selection of stable transfectants were performed in principle as described by Allen et al. (28). A list of cell lines, corresponding transfectants, and respective Ig chains expressed is given in Table I.

Table I.

Cell lines, transfectants, and Ig chains expressed


Cell line Endogenous Ig Transfectant Endogenous Ig L Transfected Ig
L H

J558L  lambda 1 J558L.gamma 3  lambda 1  gamma 3
J558L.Vlambda Cgamma 3  lambda 1 Vlambda Cgamma 3
NS1  kappa NS1.gamma 3  kappa  gamma 3
NS1.Vkappa Cgamma 3  kappa Vkappa Cgamma 3
NSFS62a  lambda FS62
NSFS62.gamma 3a  lambda FS62  gamma 3
H62 II4c.MEV VHCkappa Vkappa Cgamma 3
E7.lambda 1  lambda 1  gamma 3

a  Note that these transfectants lost endogenous NS1 kappa  Ig L chain expression.

Biosynthetic Labeling, Immunoprecipitations, Size Fractionation, and Western Blotting

As detailed elsewhere (24, 33), starved cells were labeled with [35S]methionine (>37 TBq/mmol; Amersham Corp.) and washed in phosphate-buffered saline prior to solubilization in NET lysis buffer (150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40, 50 mM Tris/HCl, pH 7.4). When indicated, wash and lysis buffer contained 20 mM NEM to prevent oxidation of free sulfhydryl groups. Immunprecipitation of Ig chains was performed with subunit-specific antibodies and/or protein A-Sepharose. Size fractionation of proteins was achieved by using a column (diameter, 1 cm; length, 40 cm) containing Sephacryl S-200HR (Pharmacia LKB, Freiburg, Germany). Proteins were separated by native or SDS-PAGE, transferred onto nitrocellulose filters by semidry blotting for Western blotting or visualized by autoradiograpy (24).

Native Gel Electrophoresis

Post-nuclear supernatant (10 µl; 4 × 107 cells/ml of NET lysis buffer) was mixed with sample buffer (30 µl; 0.1 M Tris/HCl, pH 6.8, 8.7% glycerol, 10-3% bromphenol blue) and applied onto a 6% nondenaturing slab gel. The separating gel was prepared by diluting 6 ml of a mixture containing 30% acrylamide and 0.44% bisacrylamide in 24 ml of 0.1 M glycine/NaOH, pH 9.8. The stacking gel contained 1 ml of the same acrylamide mixture, 2.5 ml of 0.5 M Tris/HCl, pH 6.8, and 6.3 ml of H2O. Electrophoresis in 0.1 M glycine/NaOH, pH 9.8, at 4 °C was done at 10 mA for 30 min until the blue dye reached the separating gel and thereafter at 20 mA for 7 h. Proteins were transferred onto nitrocellulose sheets and the Western blots developed as described below.

Immunological Reagents

All antisera were purchased from Southern Biotechnology Associates (Birmingham, AL). Affinity-purified goat anti-mouse antibody subunit-specific antisera bound to protein A-Sepharose or protein A-Sepharose alone were used for immunoprecipitations. Antibodies bearing the B1.8 idiotype react with the hapten NP (4-hydroxy-3-nitro-phenyl)acetyl (34) and could be isolated with NP-caproate coupled to Sepharose (NP-Sepharose). Western blots were developed with biotinylated affinity-purified goat anti-mouse lambda 1 or gamma 3 chain antisera, followed by a staining reaction catalyzed by streptavidin-alkaline phosphatase. Alternatively, streptavidin-horseradish conjugate was used for detection with the BM chemiluminiscence blotting substrate (Boehringer, Mannheim, Germany).


RESULTS

The kappa  chain expressed by NS1 cells is a well known example of an export-incompetent Ig L chain. Free NS1 kappa  chain is disulfide-bonded in one domain only and bound to BiP as a monomer (22), whereas the same IgL chain is secreted when associated with Ig H chain (15). Therefore, we reasoned that oligomerization might be the prerequisite for secretion of Ig L chains. This model would predict that, in the absence of Ig H chain expression, export-competent Ig L chains differ from export-incompetent Ig L chains in their capability to form homodimers.

No Antibodies Are Formed from Subunits That Both Carry the V Domain of the Export-incompetent NS1 kappa  Chain

As both export-competent and -incompetent Ig L chains may bear the same C domain (24, 35), the export competence of a free Ig L chain must be determined by its V region. That is, the V domain of the Ig L chain should determine whether or not homodimer formation is possible. To investigate this prediction, we used chimeric Ig chains in which the V regions of Ig H and L chains have been swapped. Such chimeric chains are assembled into antibodies as well as wild type chains (27). As the mode of Ig chain pairing does not seem to depend on the intramolecular V-C conjunction of the individual subunits, we can study the impact of specific V domains on chain pairing by investigating antibody formation in cells that expressed chimeric Ig chains.

Using this system, we assayed the assembly of Ig H and L chains bearing identical V domains derived from either an export-competent Ig L chain (the lambda 1 chain of J558L), or an export-incompetent Ig L chain (the kappa  chain of NS1). Hybrid genes (Vlambda Cgamma 3 and Vkappa Cgamma 3) were constructed and stable transfectants of J558L (expressing lambda 1 chains) or NS1 (expressing NS1 kappa  chains) cells established (Fig. 1; J558L.Vlambda Cgamma 3 and NS1.Vkappa Cgamma 3, respectively). In order to verify that chimeric chains can, in principle, form antibodies, we made other transfectants expressing Ig H and L chains with complementary V domains. As summarized Fig. 1 (and Table I), these include NS1.gamma 3 (endogenous kappa  and wild type gamma 3 chains), II4c.MEV (VHCkappa and Vkappa Cgamma 3 chains with mutually exchanged V domains), and J558L.gamma 3 (endogenous lambda 1 and wild type gamma 3 chains).


Fig. 1. Schematic representation of the various combinations of wild type and chimeric Ig chains expressed by stably transfected cell lines. Genes encoding chimeric Ig chains consisting of Ig H chain (white), kappa  chain (black), or lambda  chain (gray) V or C domains were constructed as described under "Experimental Procedures." The cell lines expressing the various combinations of Ig chains are indicated (see also Table I).
[View Larger Version of this Image (18K GIF file)]


To analyze the assembly state of the Ig chains, cellular proteins were biosynthetically labeled with [35S]methionine and material containing Ig H chains was isolated with protein A-Sepharose and analyzed by SDS-PAGE under non-reducing conditions (Fig. 2). In the control cell line, NS1.gamma 3 (NS1 kappa  chains and wild type gamma 3 chains), most of the Ig H chains migrated as H2L2 molecules. In addition, all covalent assembly intermediates as well as some free Ig H chains (H2 and H) were detected (Fig. 2a, lane 1). Only 40-50% of the labeled Ig L chains were associated with Ig H chains, as quantified by densitometry of the fluorograph (data not shown) seen in Fig. 2b (lanes 1 and 2), i.e. Ig L chain seems to be in a molar excess over Ig H chain. Ig chains expressed by II4c.MEV cells (VHCkappa and Vkappa Cgamma 3) differ from those of the NS1.gamma 3 cell line only by a mutual exchange of the Vkappa and VH domains. Although most intracellular II4c.MEV Ig H chains migrated as monomers under non-reducing conditions, Ig molecules were also isolated as H2L2 tetramers, H2L, HL, and H2 assembly intermediates (Fig. 2a, lane 2) in agreement with the data of Simon and Rajewsky (27). We assume that the low levels of Ig L chains synthesized by the II4c.MEV cells limited antibody formation, since all of the intracellular Ig L chains coprecipitated with the Ig H chains (Fig. 2b, compare lanes 3 and 4). In contrast, no covalently associated Ig molecules were detected in NS1.Vkappa Cgamma 3 cells, which express Ig H and L chains each bearing the V domain of the NS1 kappa  chain (Fig. 2a, lane 3). In this cell line, Ig L chain is not limiting; high levels of endogenous kappa  chain were produced (Fig. 2b, lane 5). Only traces of labeled kappa  chain (<0.5%, as determined by densitometry) were co-isolated with Ig H chain (Fig. 2b, lane 6). Thus, it seems clear that NS1 kappa  chains assemble with Ig H chains bearing the VH domain but not the Vkappa domain of NS1.


Fig. 2. Ig chain assembly in stable transfectants expressing various combinations of chimeric and wild type Ig chains. The transfectants NS1.gamma 3, II4c.MEV, NS1.Vkappa Cgamma 3, J558L.gamma 3, and J558L.Vlambda Cgamma 3 expressing the Ig chains indicated in Fig. 1 were labeled with [35S]methionine (400 µCi/4 × 106 cells/ml) for 1 h. a, Ig H chains were isolated with protein A-Sepharose from lysates prepared in the presence of 20 mM NEM. Precipitated material was analyzed by SDS-PAGE under non-reducing conditions. Migration positions of BiP, Ig H chain (H), and various assembly intermediates (HL, H2, H2L, and H2L2) are indicated. Note that H2 molecules from J558L.Vlambda Cgamma 3 (lane 5) migrate at the same position as HL intermediates from J558L.gamma 3 (lane 4) because Vlambda Cgamma 3 chains migrate faster than wild type Ig H chains. The identity of the Ig chain oligomers and of BiP was confirmed by Western blots individually developed with anti-H chain, anti-L chain, and anti-BiP antibodies (data not shown). b, total Ig chains (lanes 1, 3, 5, 7, and 9) or Ig H chains (lanes 2, 4, 6, 8, and 10) were precipitated from the same lysates analyzed in Fig. 2a by using protein A-Sepharose (PAS) alone or in combination with anti-lambda antibodies (alpha -L), as indicated, and analyzed by SDS-PAGE under reducing conditions. Note that the Ig L chains synthesized by II4c.MEV cells (lane 3) are quantitatively coprecipitated with the Ig H chains (lane 4). We noted that the cellular expression level of endogenous Ig genes was higher than that of transfected genes. Regarding the different amounts of co-isolated BiP, we know from previous work that the co-precipitation efficiency depends on the stability of the respective BiP·Ig chain complex (22), which was not analyzed here.
[View Larger Version of this Image (52K GIF file)]


In contrast, export-competent J558L lambda 1 chains assemble well with Ig H chains bearing either the VH domain or the Vlambda domain. For example, most Ig H chains in both transfectants assembled into H2L2 tetramers and covalently linked H2L and HL intermediates (Fig. 2a, lanes 4 and 5, respectively). Only part of the total intracellular Ig L chains of both J558L.gamma 3 and J558L.Vlambda Cgamma 3 coprecipitated with the Ig H chains (Fig. 2b, compare lanes 7 and 9 with lanes 8 and 10, respectively), i.e. endogenous Ig L chains were in molar excess over the vector-encoded Ig H chains.

In summary, no association is observed when both Ig H and L chains carry the V domain of the NS1 kappa  chain, indicating that the V domain of the export-incompetent Ig L chain is not capable of forming the homodomain dimers required to support Ig chain assembly. However, the individual chains are, in principle, able to assemble into antibody molecules because they assemble with partner chains that carry the V domain of the Ig H chain. Covalent assembly of Ig H and L chains also takes place when both Ig chains bear the V domain of the export-competent J558L lambda 1 chain, a result indicating that these V domains are capable of homodomain pairing.

Free Export-competent J558L lambda 1 Chains Are Secreted as Covalently and Non-covalently Linked Homodimers

Our results indicated that the V domain of the export-competent J558L lambda 1 chains could support Ig L chain homodimer formation. Indeed, J558L lambda 1 chains migrate as a single species when total cellular proteins were separated under native conditions that ought to have preserved all native complexes (Fig. 3). Together with the fact that a fraction of the J558L lambda 1 chains migrate as covalently linked dimers in non-reducing SDS-gels (24), the finding of a single band in the native gel suggests that most intracellular Ig L chains are in the same assembly state, i.e. dimers.


Fig. 3. Native gel electrophoresis of intracellular J558L lambda 1 Ig L chains. Proteins in the postnuclear supernatant of 4 × 105 solubilized J558L (lambda 1 chains; left lane) and X63Ag8.653 cells (no Ig; right lane) were separated on a native gel as described under "Experimental Procedures" and blotted onto a nitrocellulose sheet. Ig L chains were detected with an anti-lambda antiserum and alkaline phosphatase-catalyzed staining reaction.
[View Larger Version of this Image (20K GIF file)]


To verify this assumption, we analyzed total cellular proteins as well as proteins from the culture supernatant of J558L cells by gel filtration (Fig. 4). Most of the intracellular covalently linked Ig L chain dimers eluted at a position corresponding to the expected molecular mass of 55 kDa (maximum at fraction 18 in Fig. 4, left panel). Most of the non-disulfide linked Ig L chains also left the column in the dimer fraction, indicating that these Ig L chains are noncovalently linked dimers. Only a minor fraction eluted in the low molecular mass fractions from 10 to 25 kDa (fractions 23-25). The asymmetric elution profile of the noncovalently linked Ig L chains suggests that some dimers disintegrated during the gel filtration procedure (36) and, as a consequence, eluted in the lower molecular mass fractions. A similar co-elution profile of covalently and noncovalently linked Ig L chain dimers was evident with the culture supernatant (Fig. 4, right panel). The overwhelming majority of J558L lambda 1 chains form homodimers and are secreted as such; some of are covalently linked and some are not. In contrast, a similar analysis showed that the export-incompetent NS1 kappa  chain is monomeric and complexed with BiP (22).


Fig. 4. Size chromatography of intracellular and secreted J558L lambda 1 Ig L chains. Lysate (left panels) or culture supernatant (right panels) of J558L cells corresponding to 500 µl containing 300 and 350 µg of protein, respectively, was applied to a Sephacryl S-200 column. Ig L chains were immunoprecipitated from the 1-ml fractions, separated by SDS-PAGE under non-reducing conditions, and blotted onto nitrocellulose (lower panels). Covalently linked dimers (L2) or apparent monomers (L) were detected with an anti-lambda antiserum and alkaline phosphatase-catalyzed staining reaction. The signals were quantified by scanning densitometry, and the results expressed in arbitrary units (upper panels: L2, black-square; L, bullet ). The markers used to calibrate the column were alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (30 kDa), and cytochrome c (12 kDa).
[View Larger Version of this Image (38K GIF file)]


A Mutation in the lambda 1 Chain V Domain Reported to Specifically Block Ig Secretion Does Not Prevent Export of IgG in Stably Transfected Cells

It was reported that the Phe to Ser mutation at position 62 in a conserved sequence exposed on the surface of the lambda 1 chain V domain blocked the secretion of the Ig L chain whether free or associated with µ Ig H chain (37). We previously analyzed this particular Ig L chain, lambda 1 FS62, expressed in the absence of Ig H chains and showed that they are indeed not transported but are degraded instead (22). Here, we report an analysis of the export of the same Ig L chain in stably transfected cells, NSFS.gamma 3, that co-express gamma 3 Ig H chain. In contrast to the model used by Dul and Argon (37), our experiments involve (i) stable rather than transient expression and (ii) expression of gamma  rather than µ chain. We observed that lambda 1 FS62 was secreted as part of assembled IgG. In fact, IgG secretion was as efficient as in the control cell line, E7.lambda 1, which expresses gamma 3 chain in combination with a lambda 1 chain that does not carry the Phe to Ser substitution (Fig. 5). Since the mutation in the V domain of the lambda 1 chain does not lead to a general block in Ig secretion, these results demonstrate that it does not destroy a putative transport signal postulated by Dul and Argon (37).


Fig. 5. IgG secretion in cells co-expressing Ig H chains and J558L lambda 1 or lambda 1 FS62 Ig L chains. E7.lambda 1 and NSFS62.gamma 3 cells were washed and recultured (3 × 105 cells/ml) for 15 h. Antibodies contained within the lysates of cells prepared in the presence of 20 mM NEM (C) and from the corresponding cell culture supernatant (S) were isolated via their ability to bind to NP-Sepharose. The Ig H and L chains were separated by SDS-PAGE under reducing conditions and visualized by Western blotting using alkaline phosphatase. Note that the mobility of Ig H chains from culture supernatants is slower than that of intracellular Ig H chains, which might be due to a Golgi-specific processing of N-linked sugars. In control precipitations with protein A-Sepharose, most of the antibodies present in the cell lysate and in the culture supernatant of both cell lines are capable of binding NP (data not shown).
[View Larger Version of this Image (76K GIF file)]


Both Internal Disulfide Bonds Are Formed in Export-incompetent lambda 1 FS62 Chains When Paired with an Ig H Chain

Previous studies had shown that the export-incompetent lambda 1 FS62 chain, like NS1 kappa  chain, is bound to BiP as a partially oxidized molecule, whereas the export-competent J558L lambda 1 chain exhibits a fully oxidized conformation (22). In order to investigate the oxidation state of the lambda 1 FS62 chain in cells co-expressing Ig H chain, lysates of NSFS62.gamma 3 cells were prepared in the presence of N-ethylmaleimide (to prevent oxygen-mediated oxidation of thiol groups) and immunoprecipitated Ig was analyzed by Western blotting under non-reducing conditions (Fig. 6). Analysis of total Ig chains revealed two Ig L chain bands (Fig. 6, lane 4) corresponding to a partially and a completely oxidized form; both forms migrated more rapidly than completely reduced Ig L chain (compare lane 4 with lane 1). When Ig H chain-associated material was analyzed (lane 5), the co-precipitated Ig L chains migrated as fully oxidized molecules as did the J558L lambda 1 chains (lane 2). In contrast, Ig L chains remaining in the Ig H chain-depleted fraction were partially oxidized (lane 6) as they were in the absence of Ig H chain expression (lane 3). Thus, in the same cell, free lambda 1 FS62 chain is partially oxidized, while Ig L chain co-precipitated with Ig H chain is completely oxidized.


Fig. 6. Oxidation state of Ig H chain-bound and free lambda 1 FS62 chains analyzed by Western blotting. From the equivalent of 1.5 × 105 J558L (lane 2), 3 × 105 NSFS62 (lanes 1 and 3), and 3 × 105 NSFS62.gamma 3 (lanes 4-6) cells lysed in the presence of 20 mM NEM, proteins were immunoprecipitated and separated by SDS-PAGE on a 15% acrylamide gel under reducing (R; 50 mM 2-mercaptoethanol) or non-reducing (NR) conditions. The Western blot was stained for Ig H and L chains and developed using the chemiluminiscence procedure. Total Ig chains (lanes 1-4), Ig H chains (lane 5), or total Ig chains remaining after Ig H chain precipitation (lane 6) were isolated with an anti-L chain antiserum bound to protein A-Sepharose (for total Ig chains) or anti-H chain antibodies bound to protein A-Sepharose (for Ig H chain). The completely reduced Ig L chains (Red) migrate at a position different from the partially (Ox1) and the completely oxidized (Ox2) forms. The Ig H chain (H) and various assembly intermediates (HL, H2, H2L, and H2L2) are seen in the upper part of the blot, which was developed to a lower intensity as the lower part. Note that two bands are visible for Ig H chains that migrate as monomers.
[View Larger Version of this Image (42K GIF file)]


lambda 1 FS62 Chains Can Assemble with Ig H Chains as Partially Oxidized Molecules

The finding that lambda 1 FS62 chains have formed the second internal disulfide bond upon Ig H chain association raises the question whether assembly precedes oxidation of the second Ig L chain domain or is required for stabilization of completely folded lambda 1 FS62 chain. To determine the sequence of events, we performed pulse-chase experiments with NSFS62.gamma 3 cells and analyzed the oxidation state of Ig H chain-bound L chains (Fig. 7). Both fully and partially oxidized labeled Ig L chains were co-precipitated with Ig H chain isolated directly after the pulse (lane 2), indicating that Ig L chains can assemble with Ig H chains as partially oxidized molecules. The majority of labeled Ig H chains migrated as monomers (lane 2) and resolved into at least four bands (clearly visible in shorter exposed autoradiographs; data not shown), which might not only reflect Ig H chain with different glycomoiety structure but could also be due to Ig H chain with various numbers of internal disulfide bonds, as the fully reduced Ig H chain exhibited a higher apparent molecular weight and resolved into only two bands (lane 1).


Fig. 7. Oxidation state of Ig H chain-bound and free lambda 1 FS62 chains analyzed by biosynthetic labeling. NSFS62.gamma 3 were pulse-labeled for 20 min with [35S]methionine (200 µCi/2 × 106 cells/ml) and chased with an excess of unlabeled methionine for 0 or 4 h, as indicated. Cells were lysed in the presence of 20 mM NEM, and Ig chains contained in equivalent number of cells were immunoprecipitated and separated by SDS-PAGE on a 15% acrylamide gel under reducing (R; 50 mM 2-mercaptoethanol) or non-reducing (NR) conditions. Total Ig chains (lane 1), Ig H chains (lanes 2 and 3), or total Ig chains remaining after Ig H chain-precipitation (lanes 4 and 5) were isolated with an anti-L chain antiserum bound to protein A-Sepharose (for total Ig chains) or anti-H chain antibodies bound to protein A-Sepharose (for Ig H chain). Migration positions of reduced (Red), partially oxidized (Ox1), and completely oxidized (Ox2) Ig L chains as well as the Ig H chains migrating as monomers (H) or in covalently linked assembly intermediates (HL, H2, H2L, and H2L2) are indicated. It is to be noted that at least four distinct bands are resolved at the position of monomeric Ig H chains under non-reducing conditions.
[View Larger Version of this Image (65K GIF file)]


After a chase period of 4 h, a different pattern was obtained. As compared to the situation present directly after the pulse, more noncovalently linked labeled Ig L chains were co-precipitated with Ig H chain after 4 h of chase indicating that unlabeled Ig H chains synthesized during the chase associated with pre-existing labeled Ig L chains (Fig. 7, lane 3). The majority of these Ig L chains migrated as fully oxidized molecules. More label is also found with covalently linked Ig H-L chain assembly intermediates as well as with complete H2L2 molecules. Conversely, a decreased amount of labeled molecules was present in the monomeric Ig H chain pool (lane 3). Interestingly, the amount of slower migrating Ig H chain monomers was more reduced as compared to the amount of the more rapidly migrating species. This could reflect that assembly with Ig L chain allowed Ig H chain to form internal disulfide bonds that increase Ig H chain motility (33).

Consecutive precipitation of total Ig chains remaining in the Ig H chain-depleted fraction revealed that the majority of labeled intracellular Ig L chains were unassembled and partially oxidized (Fig. 7, lane 4). The presence of Ig L chains migrating as fully oxidized molecules in this fraction could be due to disassembly of the molecules from Ig H chains during the first immunoprecipitation procedure because of weak binding. Decrease in the total amount of free partially oxidized Ig L chain during the chase period (compare lanes 4 and 5) might reflect assembly with Ig H chain, on the one hand, or the degradation of free Ig L chains as is the case with these Ig L chains when expressed in the absence of Ig H chains, on the other hand (22). BiP co-immunoprecipitated with Ig H chains as well as with Ig chains present in the Ig H chain-depleted samples (lanes 2-5).

In conclusion, these experiments demonstrate that partially oxidized lambda 1 FS62 chain is able to bind Ig H chain and could oxidize in the second domain only as the result of Ig H chain co-expression. However, these experiments did not allow us to unambiguously determine the fate of partially oxidized Ig L chains in Ig H chain-expressing cells because the conversion of noncovalent Ig L-H chain complexes into covalently linked complexes interfered with the analysis of the Ig L chain oxidation state, which could only be followed in Ig L chains noncovalently associated with Ig H chain. Therefore, these data could not prove that assembly is a prerequisite for Ig L chain folding. Nevertheless, the fact that partially oxidized Ig L chains coprecipitated with Ig H chain together with the time-dependent increase in the amount of fully oxidized Ig H chain-associated L chains (that could have been recruited from the partially oxidized labeled Ig L chain pool) are compatible with the interpretation that newly synthesized partially oxidized Ig L chains can pair with Ig H chains and may fully oxidize as Ig H chain-bound molecules.


DISCUSSION

A major aim of this study was to understand the molecular basis underlying Ig chain secretion. In particular, we were puzzled by the phenomenon that some Ig L chains depend on Ig H chain association for export, whereas others are also secreted as free chains even in the absence of Ig H chain expression. The latter fact was interpreted as a possible example of polypeptides that may escape ER quality control (1). The model that led us to design the experiments was based on the information that, on the one hand, export-incompetent Ig L chains are monomeric, oxidized in one domain only, and turn into fully oxidized molecules when experimentally released from BiP interaction (22, 26). On the other hand, export-competent Ig L chains interact only transiently with BiP and are secreted as completely oxidized molecules (22, 24). The data presented here provide evidence for Ig L chain monomers having to assemble with another Ig chain prior to export. This means that export competence of an Ig L chain is determined by its capability to form homodimers in case Ig H chains are not available for assembly. Furthermore, the requirement of assembly for export could reflect that Ig L chain proceed in folding only upon chain association as demonstrated for the export-incompetent lambda 1 FS62 that forms both internal disulfide bonds only when associated with an Ig H chain.

When lambda 1 FS62 chains are co-expressed with Ig H chains, Ig H chain-bound L chains are completely oxidized whereas, in the same cell, free Ig L chains are still partially oxidized (Fig. 6). This could reflect that the partially oxidized Ig L chain is a folding intermediate used for Ig chain assembly, which implies that assembly precedes disulfide bond formation in the second Ig L chain domain. Alternatively, Ig H-L assembly could be required for stabilization of a completely folded lambda 1 FS62 chain. In favor of the first hypothesis is the fact that we never detected completely oxidized Ig L chains in the absence of Ig H chain expression. Furthermore, the results of our pulse-chase experiments showed that Ig L chains are principally able to bind to Ig H chains as partially oxidized molecules. Our attempt to determine the folding pathway of Ig L chains was impeded by the formation of covalently linked HL, H2L, and H2L2 molecules. However, the existence of assembly-competent Ig L chain folding intermediates is independently supported by the finding that Ig chain assembly is also a prerequisite for prolyl isomerization (38). Furthermore, export-competent Ig L chains accumulate in a partially oxidized conformation in COS cells that transiently overexpress a mutant BiP defective in its ATPase activity (39). From these results it seems that disulfide bond formation in one of the two Ig L chain domains is independent of BiP-ATPase function, whereas oxidation of the second domain is not. Interestingly, export-incompetent Ig L chains are in the partially oxidized form irrespective of whether the ATPase of BiP is functional or not. In the light of our results, it is tempting to speculate that oligomerization of Ig L chains is the initial step required for ATP-dependent dissociation of the BiP·L chain complex.

It seems clear that structural features intrinsic to the V domain must determine whether Ig L chains are export-competent or not as both types of Ig L chains with identical constant domains are found (24, 35). Indeed, mutations in the V domain of Ig L chains can alter their secretory phenotype (37, 40). Our experiments with the chimeric chains demonstrate that the competence of an Ig chain to assemble in vivo with another chain is strongly influenced by the nature of its V domain. For example, antibodies are formed when both chains carry the V domain of the export-competent J558L lambda 1 chain, while the chains do not associate when both subunits bear the V domain of the export-incompetent NS1 kappa  chain. It was shown that secretion of NS1 kappa  chain is restored when the histidine in position 87 is replaced by tyrosine or phenylalanine (35), suggesting that histidine 87 located in the contact surface of paired V domains (41) prevented Ig L chain homodimer formation. However, in the light of our results, the final three-dimensional structure known from crystallographic data is only achieved upon Ig chain pairing. As a consequence, amino acid residues that are not embedded in the final contact area may also be involved in the process of V domain pairing. For instance, the lambda 1 FS62 chain, which is found exclusively as unpaired monomer in NSFS62 cells, carries the mutation on the solvent accessible outer surface of the folded structure.2

If complete Ig L chain folding is required for secretion and depends on the capability of free Ig L chains to self-assemble, one should expect export-competent Ig L chains to be secreted as dimers. We found that the J558L lambda 1 chains are fully oxidized (22) and are secreted as covalently and noncovalently linked homodimers (Figs. 3 and 4). The monomeric Ig L chains reported in some cases (42) may correspond to molecules with low affinity interaction that fall apart easily when exported as noncovalently linked dimers. In fact, the in vitro analysis of 17 human kappa  Bence Jones proteins showed that the ratio between Ig L chain monomers and noncovalently linked dimers depended on the dimerization constant, which ranged from <103 to >106 M-1 (36). In this context, it is interesting to note that the dimerization constant does not necessarily correlate with the ratio between covalently and noncovalently linked Ig L chain dimers (36).

It had been suggested that V domains of Ig L chains carry a transport signal conferring export competence to the isolated Ig L chain as well as to assembled antibody molecules (37). This notion was based on experiments performed with the lambda 1 chain mutant, lambda 1 FS62, in which this putative signal was destroyed. The lambda 1 FS62 mutation not only blocked secretion of the Ig L chain itself but also led to the retention of assembled IgM in a transient transfection model. Here, we have analyzed transport of the same Ig L chain in stably transfected cells that co-express a gamma  chain and found that assembled IgG molecules were secreted. Moreover, about the same amount of IgG was secreted when the antibodies contained J558L lambda 1 or lambda 1 FS62 chains, i.e. the mutation did not alter the efficiency of antibody export. The conflicting results might be explained by the different experimental systems used to study Ig secretion; for instance, transient transfections might not ensure that sufficient amounts of both chains are expressed in the same cell. Be that as it may, however, our results exclude the possibility that a putative transport signal located on the Ig L chain had been destroyed by the FS62 mutation.

Our studies on Ig L chain assembly and secretion provide an example to illustrate how the cellular machinery could control the oligomerization state of multi-subunit proteins by monitoring the folding state of the individual subunits. In our model, oligomeric proteins would become export-competent only when the subunits proceed in folding as the result of successful assembly. Retention in the ER of unassembled subunits or of partial complexes would be due to ER chaperones binding to incompletely folded structures as does BiP with unassembled, partially oxidized Ig L chains (22). This view clearly differs from a model in which the role of BiP is to cover the hydrophobic interface of a non-assembled folded subunit (1). The observation that BiP binding prevents complete oxidation of unassembled Ig L chains (22, 39) strongly indicates that BiP interferes with the in vivo folding pathway of Ig chains. A quality control mechanism that monitors oligomerization at the level of subunit folding could not exclude the formation of different oligomers when subunits fulfill their folding requirements by assembling with various partner chains. For example, Ig L chains pass the export checkpoint by forming either heterodimeric antibody molecules or Ig L homodimers. The thiol-mediated retention described by Sitia and co-workers (18) monitors the oligomerization state of normally covalently linked subunits and may act as a second mechanism to retain folded molecules that still exhibit free thiol groups (17, 21). As beta 2-microglobulin also exhibits an Ig fold structure and molecules can be exported without major histocompatibility complex class I H chain association, our model predicts that free beta 2-microglobulin might form homodimers prior to exit from the ER.


FOOTNOTES

*   This work was supported in part by Grant SFB352 of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Recipient of a Ph.D. fellowship from the Boehringer Ingelheim Zülpicher Str. 47, Fonds. Present address: Institut für Genetik der Universität zu Köln, D-50674 Köln, Germany.
§   Recipient of a Heisenberg award from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed. Tel.: 49-6221-54-5488; Fax: 49-6221-54-4366; E-mail: im7{at}ix.urz.uniheidelberg.de.
1    The abbreviations used are: ER, endoplasmic reticulum; Ig, immunoglobulin; H, heavy; L, light; V, variable; C, constant; NEM, N-ethylmaleimide; PAGE, polyacryalamide gel electrophoresis; NP, X: (4-hydroxy-3-nitrophenyl)acetyl.
2    M. R. Knittler and I. G. Haas, unpublished results.

Acknowledgments

We thank T. Simon for the generous gift of vectors, cells, and reagents and H.-M. Jäck, T. Neubert, C. Steinberg, H. Tschochner, and F. Wieland for discussions and critical reading of the manuscript.


REFERENCES

  1. Hammond, C., and Helenius, A. (1995) Curr. Opin. Cell Biol. 7, 523-529 [CrossRef][Medline] [Order article via Infotrieve]
  2. Hurtley, S. M., Bole, D. G., Hoover, L. H., Helenius, A., and Copeland, C. S. (1989) J. Cell Biol. 108, 2117-26 [Abstract]
  3. Klausner, R. D. (1989) New Biol. 1, 3-8 [Medline] [Order article via Infotrieve]
  4. Kreis, T. E., and Lodish, H. F. (1986) Cell 46, 929-937 [Medline] [Order article via Infotrieve]
  5. Hurtley, S. M., and Helenius, A. (1989) Annu. Rev. Cell Biol. 5, 277-307 [CrossRef]
  6. Gething, M.-J., McCammon, K., and Sambrook, J. (1986) Cell 46, 939-950 [Medline] [Order article via Infotrieve]
  7. Klausner, R. D., Lippincott-Schwartz, J., and Bonifacino, J. S. (1990) Annu. Rev. Cell Biol. 6, 403-431 [CrossRef]
  8. Ploegh, H. L., Orr, H. T., and Strominger, J. L. (1981) Cell 24, 287-299 [Medline] [Order article via Infotrieve]
  9. Arce-Gomez, B., Jones, E. A., Barnstable, C. J., Solomon, E., and Bodmer, W. F. (1978) Tissue Antigens 11, 96-112 [Medline] [Order article via Infotrieve]
  10. Burrows, P., LeJeune, M., and Kearney, J. F. (1979) Nature 280, 838-841 [Medline] [Order article via Infotrieve]
  11. Morrison, S. L., and Scharff, M. D. (1975) J. Immunol. 114, 655-659 [Abstract]
  12. Sonenshein, G. E., Siekevitz, M., Siebert, G. R., and Gefter, M. L. (1978) J. Exp. Med. 148, 301-311 [Abstract]
  13. Shapiro, A. L., Scharff, M. D., Maizel, J. V., Jr., and Uhr, J. W. (1966) Nature 211, 243-245 [Medline] [Order article via Infotrieve]
  14. Baumal, R., and Scharff, M. D. (1973) J. Immunol. 111, 448-456 [Medline] [Order article via Infotrieve]
  15. Köhler, G., Howe, S. C., and Milstein, C. (1976) Eur. J. Immunol. 6, 292-295 [Medline] [Order article via Infotrieve]
  16. Oi, V. T., Morrison, S. L., Herzenberg, L. A., and Berg, P. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 825-829 [Abstract]
  17. Sitia, R., Neuberger, M., Alberini, C., Bet, P., Fra, A., Valetti, C., Williams, G., and Milstein, C. (1990) Cell 60, 781-790 [Medline] [Order article via Infotrieve]
  18. Alberini, C. M., Bet, P., Milstein, C., and Sitia, R. (1990) Nature 347, 485-487 [CrossRef][Medline] [Order article via Infotrieve]
  19. Guenzi, S., Fra, A. M., Sparvoli, A., Bet, P., Rocco, M., and Sitia, R. (1994) Eur. J. Immunol. 24, 2477-2482 [Medline] [Order article via Infotrieve]
  20. Fra, A. M., Fagioli, C., Finazzi, D., Sitia, R., and Alberini, C. M. (1993) EMBO J. 12, 4755-4761 [Abstract]
  21. Reddy, P., Sparvoli, A., Fagioli, C., Fassina, G., and Sitia, R. (1996) EMBO J. 15, 2077-2085 [Abstract]
  22. Knittler, M. R., Dirks, S., and Haas, I. G. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1764-1768 [Abstract]
  23. Milstein, C. (1965) Nature 205, 1171-1173
  24. Knittler, M. R., and Haas, I. G. (1992) EMBO J. 11, 1573-1581 [Abstract]
  25. Haas, I. G., and Wabl, M. (1983) Nature 306, 387-389 [Medline] [Order article via Infotrieve]
  26. Cremer, A., Knittler, M. R., and Haas, I. G. (1994) in Glyco- and Cellbiology (Wieland, F., and Reutter, W., eds), pp. 171-184, Springer-Verlag, Berlin
  27. Simon, T., and Rajewsky, K. (1990) EMBO J. 9, 1051-1056 [Abstract]
  28. Allen, D., Simon, T., Sablitzky, F., Rajewsky, K., and Cumano, A. (1988) EMBO J. 7, 1995-2001 [Abstract]
  29. Brinster, R. L., Ritchie, K. A., Hammer, R. E., O'Brien, R. L., Arp, B., and Storb, U. (1983) Nature 306, 332-336 [Medline] [Order article via Infotrieve]
  30. Weiss, S., Lehmann, K., and Cohn, M. (1985) Eur. J. Immunol. 15, 768-772 [Medline] [Order article via Infotrieve]
  31. Kearney, J. F., Radbruch, A., Liesegang, B., and Rajewsky, K. (1979) J. Immunol. 123, 1548-1550 [Abstract]
  32. Haas, I. G., and Wabl, M. R. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 7185-7188 [Abstract]
  33. Kaloff, C. R., and Haas, I. G. (1995) Immunity 2, 629-637 [Medline] [Order article via Infotrieve]
  34. Reth, M., Hammerling, G. J., and Rajewsky, K. (1978) Eur. J. Immunol. 8, 393-400 [Medline] [Order article via Infotrieve]
  35. Dul, J. L., Burrone, O. R., and Argon, Y. (1992) J. Immunol. 149, 1927-1933 [Abstract/Free Full Text]
  36. Stevens, F. J., Westholm, F. A., Solomon, A., and Schiffer, M. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 1144-1148 [Abstract]
  37. Dul, J. L., and Argon, Y. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 8135-8139 [Abstract]
  38. Lilie, H., Rudolph, R., and Buchner, J. (1995) J. Mol. Biol. 248, 190-201 [CrossRef][Medline] [Order article via Infotrieve]
  39. Hendershot, L., Wei, J., Gaut, J., Melnick, J., Aviel, S., and Argon, Y. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5269-5274 [Abstract/Free Full Text]
  40. Wu, G. E., Hozumi, N., and Murialdo, H. (1983) Cell 33, 77-83 [CrossRef][Medline] [Order article via Infotrieve]
  41. Chothia, C., Novotny, J., Bruccoleri, R., and Karplus, M. (1985) J. Mol. Biol. 186, 651-663 [Medline] [Order article via Infotrieve]
  42. Masat, L., Wabl, M., and Johnson, J. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 893-896 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.